This is a multicenter, active-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 4-week treatment with Stillen tab. in patients with acute or chronic gastritis. Subject will receive Stillen tab or Mucosta tab., three times a day for four weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
258
Yonsei University Health System, Severance Hospital, IRB
Seoul, South Korea
Improvement rates of erosive gastritis
Improvement rates of erosive gastritis (%) = (improved cases)/(total cases administered) \* 100
Time frame: 4 weeks
Healing rates of erosive gastritis
Healing rates of erosive gastritis (%) = (healed cases)/(total cases administered)\*100
Time frame: 4 weeks
Symptoms improved level
Time frame: 4 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.